title: Arsenic trioxide - An old drug rediscovered.
abstract: Over the last 17 years, clinical trials conducted worldwide have demonstrated the efficacy of arsenic trioxide (As(2)O(3)) in the treatment of relapsed acute promyelocytic leukemia (APL). Currently, the role of As(2)O(3) in front-line therapy is under investigation. Recent trials in the US have demonstrated that the addition of As(2)O(3) to standard treatment regimens improves survival outcomes in patients with APL and may allow a reduction in cytotoxic chemotherapy exposure. As(2)O(3) has also shown efficacy in other malignancies, particularly multiple myeloma and myelodysplastic syndromes. Therapeutic doses of As(2)O(3) are well tolerated, with no evidence of long-term toxicity. Adverse events include APL differentiation syndrome, electrocardiographic abnormalities, and mild elevations in liver enzymes. This review highlights trials investigating the role of As(2)O(3) in induction and consolidation for newly diagnosed APL, as well as its role in other hematologic malignancies. The chemistry, mechanisms of action, and clinical side effects of As(2)O(3) are also discussed.
authors.affiliation: Johns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231-1000, United States. aemadi1@jhmi.edu
authors.forename: Ashkan
authors.initials: A
authors.lastname: Emadi
authors.forename: Steven D
authors.initials: SD
authors.lastname: Gore
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D010087:Oxides / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide
references.citation: Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5328-35
references.pmid: 15044693
references.citation: Leuk Res. 2004 Aug;28(8):791-803
references.pmid: 15203277
references.citation: J Clin Oncol. 2001 Sep 15;19(18):3852-60
references.pmid: 11559723
references.citation: Leukemia. 2002 Sep;16(9):1888
references.pmid: 12200720
references.citation: Annu Rev Pharmacol Toxicol. 1997;37:397-419
references.pmid: 9131259
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3342-7
references.pmid: 19225113
references.citation: J Biol Chem. 1992 Jun 5;267(16):11366-73
references.pmid: 1597467
references.citation: Zhonghua Wai Ke Za Zhi. 2006 Jun 15;44(12):805-8
references.pmid: 16889724
references.citation: Clin Cancer Res. 2007 Mar 15;13(6):1762-8
references.pmid: 17363530
references.citation: Blood. 1997 May 1;89(9):3487-8
references.pmid: 9129058
references.citation: Science. 1997 Feb 21;275(5303):1132-6
references.pmid: 9027315
references.citation: Leukemia. 2004 Sep;18(9):1518-21
references.pmid: 15269785
references.citation: Cancer Res. 2003 Apr 15;63(8):1853-9
references.pmid: 12702573
references.citation: Blood. 2009 Jun 25;113(26):6528-32
references.pmid: 19411628
references.citation: J Biol Chem. 1999 Jun 18;274(25):17941-5
references.pmid: 10364241
references.citation: N Engl J Med. 1998 Nov 5;339(19):1341-8
references.pmid: 9801394
references.citation: Br J Haematol. 1997 Dec;99(3):625-31
references.pmid: 9401076
references.citation: Cancer Res. 1999 Mar 1;59(5):1041-8
references.pmid: 10070961
references.citation: J Clin Oncol. 2006 Jun 1;24(16):2456-64
references.pmid: 16651647
references.citation: Br J Haematol. 2006 Oct;135(2):174-83
references.pmid: 17010047
references.citation: Leuk Lymphoma. 2004 Dec;45(12):2387-401
references.pmid: 15621751
references.citation: Hematol J. 2004;5(2):130-4
references.pmid: 15048063
references.citation: Cell. 1994 Jan 28;76(2):333-43
references.pmid: 8293467
references.citation: Clin Cancer Res. 2002 Dec;8(12):3658-68
references.pmid: 12473574
references.citation: Blood. 1999 Jan 1;93(1):268-77
references.pmid: 9864170
references.citation: Blood. 1997 May 1;89(9):3354-60
references.pmid: 9129042
references.citation: J Clin Oncol. 2006 Dec 20;24(36):5703-10
references.pmid: 17116939
references.citation: Haematologica. 2006 Dec;91(12):1722-3
references.pmid: 17145617
references.citation: Br J Haematol. 2002 Mar;116(3):555-63
references.pmid: 11849211
references.citation: Blood. 2005 May 15;105(10):4004-12
references.pmid: 15677571
references.citation: J Clin Oncol. 2006 Jun 1;24(16):2465-71
references.pmid: 16651646
references.citation: J Biol Chem. 2000 Nov 17;275(46):36062-6
references.pmid: 10967126
references.citation: Leuk Res. 2007 Nov;31(11):1585-7
references.pmid: 17416415
references.citation: Blood. 2004 Feb 15;103(4):1237-43
references.pmid: 14576047
references.citation: Biol Pharm Bull. 2006 May;29(5):1022-7
references.pmid: 16651738
references.citation: Oncologist. 2001;6 Suppl 2:3-10
references.pmid: 11331434
references.citation: Haematologica. 2006 Aug;91(8):1105-8
references.pmid: 16870552
references.citation: Biol Blood Marrow Transplant. 2008 Dec;14(12):1401-7
references.pmid: 19041063
references.citation: Leukemia. 2003 Aug;17(8):1499-507
references.pmid: 12886236
references.citation: J Clin Oncol. 2010 Feb 20;28(6):1047-53
references.pmid: 20085935
references.citation: Hematol Oncol. 2009 Mar;27(1):11-6
references.pmid: 18668698
references.citation: Nature. 2000 Oct 12;407(6805):770-6
references.pmid: 11048727
references.citation: Int J Biochem Cell Biol. 2008;40(5):1016-29
references.pmid: 18160327
references.citation: J Biol Chem. 1999 Apr 23;274(17):11549-56
references.pmid: 10206961
references.citation: Leukemia. 2002 Sep;16(9):1835-7
references.pmid: 12200700
references.citation: Biochem Pharmacol. 1998 Jun 1;55(11):1747-58
references.pmid: 9714292
references.citation: Leukemia. 1998 Sep;12(9):1383-91
references.pmid: 9737686
references.citation: Biochem Biophys Res Commun. 2001 Aug 31;286(4):726-34
references.pmid: 11520058
references.citation: Blood. 2007 Jul 1;110(1):59-66
references.pmid: 17374742
references.citation: Med Oncol. 2006;23(2):263-72
references.pmid: 16720927
references.citation: Blood. 2008 Mar 1;111(5):2505-15
references.pmid: 18299451
references.citation: J Natl Cancer Inst. 1999 May 5;91(9):772-8
references.pmid: 10328107
references.citation: Nat Genet. 1998 Nov;20(3):266-72
references.pmid: 9806545
references.citation: Chem Res Toxicol. 2004 Jan;17(1):95-103
references.pmid: 14727923
references.citation: Cancer Lett. 2008 Jul 18;266(1):53-9
references.pmid: 18362051
references.citation: Cancer. 2005 Oct 15;104(8):1687-92
references.pmid: 16130126
references.citation: Haematologica. 2007 May;92(5):719-20
references.pmid: 17488707
references.citation: Yao Xue Xue Bao. 2008 Jan;43(1):35-43
references.pmid: 18357729
references.citation: Blood. 2009 Feb 26;113(9):1875-91
references.pmid: 18812465
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4578-83
references.pmid: 15070760
references.citation: Invest New Drugs. 2002 Aug;20(3):327-30
references.pmid: 12201495
references.citation: Blood. 2001 Aug 1;98(3):805-13
references.pmid: 11468182
references.citation: Am J Med Sci. 1988 Aug;296(2):85-6
references.pmid: 2456695
references.citation: Cancer Res. 2002 Jul 15;62(14):3893-903
references.pmid: 12124315
references.citation: Cancer Res. 2003 May 1;63(9):2103-8
references.pmid: 12727826
references.citation: Blood. 2006 Apr 1;107(7):2627-32
references.pmid: 16352810
references.citation: Br J Haematol. 2004 May;125(4):470-6
references.pmid: 15142117
references.citation: Inorg Chem. 2005 Apr 18;44(8):2964-72
references.pmid: 15819584
references.citation: Cancer Res. 2000 Jun 1;60(11):3065-71
references.pmid: 10850458
references.citation: Blood. 1997 May 1;89(9):3345-53
references.pmid: 9129041
references.citation: Cancer Chemother Pharmacol. 2007 Mar;59(4):485-93
references.pmid: 16937107
references.citation: Invest New Drugs. 2007 Feb;25(1):77-84
references.pmid: 16937079
references.citation: J Clin Oncol. 2009 Feb 1;27(4):504-10
references.pmid: 19075265
references.citation: Exp Cell Res. 1999 Jun 15;249(2):413-21
references.pmid: 10366441
references.citation: Cancer. 2008 Mar 1;112(5):1131-8
references.pmid: 18286511
references.citation: Leukemia. 2005 Jan;19(1):154-6
references.pmid: 15496977
references.citation: Cancer. 2008 Nov 1;113(9):2504-11
references.pmid: 18825661
references.citation: Leuk Res. 2008 Feb;32(2):251-4
references.pmid: 17920679
references.citation: Blood. 1996 Aug 1;88(3):1052-61
references.pmid: 8704214